| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |